Philipp Spycher | Psi Founder Fellow
Paul Scherrer Institut

Dr. Spycher is a PSI Founder Fellow at the Paul Scherrer Institute (PSI) Villigen (Switzerland) working on the site-specific modification of native antibodies. He is a co-founder of the PSI spin-off Araris Biotech AG, incorporated in January 2019, that is focused on ADCs and advancing the newly developed ADC linker technology. During his doctoral studies at ETH Zurich, he worked on protein and materials engineering. He then performed a post-doc at PSI Villigen on the site-specific modification of antibodies and fragments using enzymes for diagnostic and therapeutic applications that resulted in two filed patents and several high-impact publications. Dr. Spycher has over 8 years experience with ADCs, he is particularly interested in the development of drug delivery systems for improved targeting.